CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Edit Your Profile

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY Journal

publication venue for

Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID-19 pandemic: the THOCOoP cooperative group 2020
Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB) 2020
Prognostic and predictive factors in patients with brain metastases from solid tumors: A review of published nomograms 2018
Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients 2017
BRAF mutations in non-small cell lung cancer: has finally Janus opened the door? 2016
Therapeutic management of metastatic brain tumors 2007
Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma? 2006
Continent urinary diversion and low colorectal anastomosis after pelvic exenteration. Quality of life and complication risk 2003
Guidelines of how to manage vesicovaginal fistula 2003
Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB) (vol 151, 102978, 2020) 2020

category

HEMATOLOGY Category
ONCOLOGY Category

International Standard Serial Number (ISSN)

1040-8428

Electronic International Standard Serial Number (EISSN)

1879-0461

journal abbreviation

CRIT REV ONCOL HEMAT